BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9265909)

  • 1. The application of neuroimaging techniques to drug development.
    Tamminga CA; Conley RR
    J Clin Psychiatry; 1997; 58 Suppl 10():3-6. PubMed ID: 9265909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of positron emission tomography in neuropharmacology in the living human brain and drug development].
    Yanai K; Tagawa M
    Nihon Rinsho; 2000 Oct; 58(10):2149-57. PubMed ID: 11068462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of positron emission tomography in neuropharmacology in the living human brain and drug development].
    Yanai K
    Nihon Yakurigaku Zasshi; 1999 Sep; 114(3):169-78. PubMed ID: 10553580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroimaging in psychiatry: An update.
    Abou-Saleh MT
    J Psychosom Res; 2006 Sep; 61(3):289-93. PubMed ID: 16938503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic drug action: targets for drug discovery with neurochemical imaging.
    Stone JM; Pilowsky LS
    Expert Rev Neurother; 2006 Jan; 6(1):57-64. PubMed ID: 16466312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding neuroimaging.
    Kimberley TJ; Lewis SM
    Phys Ther; 2007 Jun; 87(6):670-83. PubMed ID: 17429004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent progress in diagnostic imaging of cerebrovascular diseases].
    Hatazawa J
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1254-6. PubMed ID: 11464471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of functional neuroimaging in pediatric brain injury.
    Munson S; Schroth E; Ernst M
    Pediatrics; 2006 Apr; 117(4):1372-81. PubMed ID: 16585335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of imaging in the early development of neuropharmacological drugs: a survey of approved NDAs.
    Uppoor RS; Mummaneni P; Cooper E; Pien HH; Sorensen AG; Collins J; Mehta MU; Yasuda SU
    Clin Pharmacol Ther; 2008 Jul; 84(1):69-74. PubMed ID: 18563070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of clinical dopamine imaging.
    Lindsey KP; Gatley SJ
    Neuroimaging Clin N Am; 2006 Nov; 16(4):553-73, vii-viii. PubMed ID: 17148019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New diagnostic imaging methods in neurosurgery: advent of anatomical and functional neuroimaging].
    Oishi M; Uzuka T; Yoneoka Y; Fujii Y; Igarashi H
    No Shinkei Geka; 2007 Mar; 35(3):291-300. PubMed ID: 17352155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human brain mapping: hemodynamic response and electrophysiology.
    Shibasaki H
    Clin Neurophysiol; 2008 Apr; 119(4):731-43. PubMed ID: 18187361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of antipsychotic treatment on cerebral structure and function in schizophrenia.
    Vita A; De Peri L
    Int Rev Psychiatry; 2007 Aug; 19(4):429-36. PubMed ID: 17671875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of brain imaging techniques in mental illness.
    Andreasen NC
    Annu Rev Med; 1988; 39():335-45. PubMed ID: 3285780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging CNS receptors: the dopaminergic system.
    Wagner HN
    Hosp Pract (Off Ed); 1984 Jun; 19(6):187-91, 195-8, 202. PubMed ID: 6144688
    [No Abstract]   [Full Text] [Related]  

  • 16. Time-dependent effects of a haloperidol challenge on energy metabolism in the normal human brain.
    Bartlett EJ; Brodie JD; Simkowitz P; Dewey SL; Rusinek H; Volkow ND; Wolf AP; Smith G; Wolkin A; Cancro R
    Psychiatry Res; 1996 Mar; 60(2-3):91-9. PubMed ID: 8723299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current state and vision of the development of new antipsychotic drugs].
    Takekita Y; Kinoshita T
    Nihon Rinsho; 2013 Apr; 71(4):730-6. PubMed ID: 23678608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET-based neuropharmacology: state of the art.
    Lucignani G; Moresco RM; Fazio F
    Cerebrovasc Brain Metab Rev; 1989; 1(4):271-87. PubMed ID: 2701655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human brain imaging and substance abuse.
    Lingford-Hughes A
    Curr Opin Pharmacol; 2005 Feb; 5(1):42-6. PubMed ID: 15661624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonhuman primate neuroimaging and the neurobiology of psychostimulant addiction.
    Howell LL; Murnane KS
    Ann N Y Acad Sci; 2008 Oct; 1141():176-94. PubMed ID: 18991958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.